# Alpine Immune Sciences (stock symbol: ALPN) Logo in transparent PNG format

## Alpine Immune Sciences Logo large

### Alpine Immune Sciences Logo large Download PNG (6.06 KB)

![Alpine Immune Sciences Logo large Download PNG (6.06 KB)](/img/orig/ALPN_BIG-c8086327.png)

## Alpine Immune Sciences Logo icon format

### Alpine Immune Sciences Logo icon format Download PNG (2.12 KB)

![Alpine Immune Sciences Logo icon format Download PNG (2.12 KB)](/img/orig/ALPN-fe51b893.png)

## Alpine Immune Sciences Logo large for dark backgrounds

### Alpine Immune Sciences Logo large for dark backgrounds Download PNG (7.87 KB)

![Alpine Immune Sciences Logo large for dark backgrounds Download PNG (7.87 KB)](/img/orig/ALPN_BIG.D-5b02fc38.png)

## Alpine Immune Sciences Logo icon format for dark backgrounds

### Alpine Immune Sciences Logo icon format for dark backgrounds Download PNG (1.71 KB)

![Alpine Immune Sciences Logo icon format for dark backgrounds Download PNG (1.71 KB)](/img/orig/ALPN.D-70af8ac7.png)

## About Alpine Immune Sciences

Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for the treatment of B cell-mediated inflammatory and autoimmune diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.

1. Website domain: alpineimmunesciences.com
2. Employees: 85
3. Marketcap: $0.35 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
